Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Supporting Rural Community Emergency Planning, Response, and Recovery.
Kappel R, Chavez A, Melnick M, Siegfried AL. Kappel R, et al. Among authors: melnick m. J Public Health Manag Pract. 2024 Jan-Feb 01;30(1):130-132. doi: 10.1097/PHH.0000000000001823. Epub 2023 Sep 15. J Public Health Manag Pract. 2024. PMID: 37713642
Limited restoration of contrast sensitivity with training after V1 damage in humans.
Yang 杨菁艺 J, Saionz EL, Cavanaugh MR, Fahrenthold BK, Melnick MD, Tadin D, Briggs F, Carrasco M, Huxlin KR. Yang 杨菁艺 J, et al. Among authors: melnick md. eNeuro. 2024 Feb 23;11(3):ENEURO.0020-24.2024. doi: 10.1523/ENEURO.0020-24.2024. Online ahead of print. eNeuro. 2024. PMID: 38395611 Free PMC article.
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Hu B, Wiesehöfer M, de Miguel FJ, Liu Z, Chan LH, Choi J, Melnick MA, Arnal Estape A, Walther Z, Zhao D, Lopez-Giraldez F, Wurtz A, Cai G, Fan R, Gettinger S, Xiao A, Yan Q, Homer R, Nguyen DX, Politi K. Hu B, et al. Among authors: melnick ma. Cancer Res. 2024 Apr 15;84(8):1303-1319. doi: 10.1158/0008-5472.CAN-23-0438. Cancer Res. 2024. PMID: 38359163
Contrast sensitivity: a fundamental limit to vision restoration after V1 damage.
Yang J, Saionz EL, Cavanaugh MR, Fahrenthold BK, Melnick MD, Tadin D, Briggs F, Carrasco M, Huxlin KR. Yang J, et al. Among authors: melnick md. medRxiv [Preprint]. 2023 Sep 2:2023.08.31.23294827. doi: 10.1101/2023.08.31.23294827. medRxiv. 2023. PMID: 37693553 Free PMC article. Preprint.
Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer.
de Miguel FJ, Gentile C, Feng WW, Silva SJ, Sankar A, Exposito F, Cai WL, Melnick MA, Robles-Oteiza C, Hinkley MM, Tsai JA, Hartley AV, Wei J, Wurtz A, Li F, Toki MI, Rimm DL, Homer R, Wilen CB, Xiao AZ, Qi J, Yan Q, Nguyen DX, Jänne PA, Kadoch C, Politi KA. de Miguel FJ, et al. Among authors: melnick ma. Cancer Cell. 2023 Aug 14;41(8):1516-1534.e9. doi: 10.1016/j.ccell.2023.07.005. Epub 2023 Aug 3. Cancer Cell. 2023. PMID: 37541244 Free article.
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer.
Adua SJ, Arnal-Estapé A, Zhao M, Qi B, Liu ZZ, Kravitz C, Hulme H, Strittmatter N, López-Giráldez F, Chande S, Albert AE, Melnick MA, Hu B, Politi K, Chiang V, Colclough N, Goodwin RJA, Cross D, Smith P, Nguyen DX. Adua SJ, et al. Among authors: melnick ma. Nat Commun. 2022 Dec 12;13(1):7690. doi: 10.1038/s41467-022-34889-z. Nat Commun. 2022. PMID: 36509758 Free PMC article.
230 results